Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mixed Liver Injury”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Not applicableLooking for participantsNCT00345930
What this trial is testing

DILIN - Prospective Study

Who this might be right for
Liver Diseases
Duke University 4,000
Large-scale testing (Phase 3)Study completedNCT00652132
What this trial is testing

Cisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, II, or III Childhood Liver Cancer

Who this might be right for
Liver CancerOtotoxicity
University of Birmingham 116
Not applicableLooking for participantsNCT00360646
What this trial is testing

Drug-Induced Liver Injury (DILI) Network Retrospective

Who this might be right for
Drug Induced Liver Injury
Duke University 400
Testing effectiveness (Phase 2)UnknownNCT06019936
What this trial is testing

A Randomized,Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of MT2004 Capsule in DILI Subjects

Who this might be right for
Drug-Induced Liver InjuryCholestatic Liver InjuryMixed Liver Injury
Xi'An Aolitai Pharmaceutical Technology Co Ltd 80
Large-scale testing (Phase 3)Study completedNCT00716976
What this trial is testing

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Who this might be right for
Brain TumorCentral Nervous System TumorChildhood Germ Cell Tumor+6 more
Children's Oncology Group 131